Prednisone 5 Mg Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets / Oral solution
Available Strengths: 1 mg, 2.5 mg, 5 mg, 5 mg/5 mL
Reference Brands: Deltasone (USA), Prednicot (USA)
Category:
Immune Disorder
Prednisone is a synthetic corticosteroid used to suppress inflammation and modulate the immune system. It is commonly prescribed for allergic reactions, autoimmune diseases, asthma, rheumatoid arthritis, and certain cancers. Prednisone works by reducing inflammation and altering the body’s immune response, helping control symptoms and prevent tissue damage.
Prednisone 5 mg Tablet is available in Tablets / Oral solution
and strengths such as 1 mg, 2.5 mg, 5 mg, 5 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Prednisone 5 mg Tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Prednisone 5 mg Tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Prednisone is a synthetic glucocorticoid that is converted in the liver to its active metabolite, prednisolone. It exerts potent anti-inflammatory and immunosuppressive effects by regulating immune system activity and suppressing the production of inflammatory mediators. Due to its broad mechanism of action, prednisone is widely indicated across multiple therapeutic areas, including endocrine disorders, rheumatic and autoimmune diseases, allergic conditions, dermatologic and ophthalmic disorders, respiratory illnesses, hematologic and neoplastic diseases, as well as gastrointestinal inflammatory conditions.
Prednisone is used in both acute and chronic disease management and is available in immediate-release and delayed-release formulations. Delayed-release variants provide flexibility in dosing time and are particularly beneficial for conditions with circadian symptom variation, such as inflammatory arthritis. The drug’s pharmacokinetic profile supports oral administration with predictable systemic activity when appropriately dosed.
Clinical use of prednisone requires careful consideration of dosing strategies, duration of therapy, and patient-specific factors. Potential adverse effects include immunosuppression, osteoporosis, glucose intolerance, and adrenal suppression, especially with long-term use. Close monitoring, awareness of drug interactions, and interprofessional coordination are essential to optimize therapeutic outcomes while minimizing risks, making prednisone a cornerstone therapy in inflammatory disease management.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing